Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “extracellular”

61 pharma patents match "extracellular" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 61
Index total 30,257
Page 3 / 3

Quick answer

This filtered view shows 61 pharmaceutical patents matching "extracellular" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

61 results for “extracellular” · 30,257 patents in full index Clear search

  1. US 8183207

    Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted

  2. US 8105609

    Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted

  3. US 8080554

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  4. US 8080246

    Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  5. US 7723472

    Extracellular matrix binding chimeric proteins and methods of use thereof

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted

  6. US 7300660

    Abundant extracellular products and methods for their production and use

    The Regents of the University of California · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted

  7. US 7002002

    Abundant extracellular products and methods for their production and use

    The Regents of the University of California · Granted Feb 21, 2006 · Expires Feb 16, 2026

    expired

  8. US 6818223

    Abundant extracellular products and methods for their production and use

    The Regents of the University of California · Granted Nov 16, 2004 · Expires Nov 11, 2024

    expired

  9. US 6761894

    Abundant extracellular products and methods for their production and use

    The Regents of the University of California · Granted Jul 13, 2004 · Expires Jul 8, 2024

    expired

  10. US 6752993

    Abundant extracellular product vaccines and methods for their production and use

    The Regents of the University of California · Granted Jun 22, 2004 · Expires Jun 17, 2024

    expired

  11. US 6737511

    Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis

    The United States of America, as represented by the Department of Health and Human Services · Granted May 18, 2004 · Expires May 13, 2024

    expired

  12. US 6599510

    Abundant extracellular products and methods for their production and use

    The Regents of the University of California · Granted Jul 29, 2003 · Expires Jul 24, 2023

    expired

  13. US 6150508

    Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen

    Northwest Biotherapeutics, Inc. · Granted Nov 21, 2000 · Expires Nov 16, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.